Healthcare
Live Price
Offline$0.00001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 8, 2026
Coverage: 241 bars · Jun 23, 2025 → Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Radient Technologies Inc. (RDDTF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 8, 2026). Baseline metrics include revenue growth of +45.5%, EPS growth of +78.0%, a dividend yield of 0.0%. What stands out right now is revenue +45.5%, EPS +78.0%, free cash flow +75.2% with operating margin 0.0% and ROIC 0.0%. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RDDTF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RDDTF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RDDTF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RDDTF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$455.8K
+112.9% YoY
FY Net Income
-$14.0M
+49.6% YoY
Free Cash Flow
-$9.6M
+66.2% YoY
Revenue Growth
+45.5%
EPS Growth
+78.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
CAD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 4M | 2M | 18M | 214K | 456K |
| Gross Profit | 188K | -496K | 448K | 83K | 195K |
| Operating Income | -7M | -14M | -26M | -28M | -8M |
| EBITDA | -9M | -38M | -34M | -26M | -13M |
| Net Income | -13M | -42M | -37M | -28M | -14M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 32K | 486K | 145K | 32M | 22M |
| Total Assets | 28M | 29M | 58M | 61M | 30M |
| Total Liabilities | 38M | 32M | 39M | 10M | 4M |
| Shareholder Equity | -10M | -3M | 19M | 51M | 26M |
| Total Debt | 14M | 12M | 15M | 7M | 2M |
| Net Debt | 14M | 11M | 15M | -25M | -20M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
8M
+45.9% YoY
Capital Expenditures
1M
+89.9% YoY
Free Cash Flow
10M
+66.2% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
0.0%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.